Europe Small Molecule Drug Delivery Market

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Analysis by Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas); Process/Phase (Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development), and Country

No. of Pages: 138
Report Code: TIPRE00013000
Category: Life Sciences
Europe Small Molecule Drug Delivery Market
Free Sample Buy Now

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Small Molecule Drug Delivery Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Small Molecule Drug Delivery Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Small Molecule Drug Delivery Market Regional Analysis

6.2 Europe Small Molecule Drug Delivery Market Revenue 2017-2027 (US$ Million)
6.3 Europe Small Molecule Drug Delivery Market Forecast Analysis

7. Europe Small Molecule Drug Delivery Market Analysis – by Therapeutic Area

7.1 Oncology
  • 7.1.1 Overview
  • 7.1.2 Oncology: Europe Small Molecule Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Central Nervous System
  • 7.2.1 Overview
  • 7.2.2 Central Nervous System: Europe Small Molecule Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Cardiovascular
  • 7.3.1 Overview
  • 7.3.2 Cardiovascular: Europe Small Molecule Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Respiratory
  • 7.4.1 Overview
  • 7.4.2 Respiratory: Europe Small Molecule Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Orthopedics
  • 7.5.1 Overview
  • 7.5.2 Orthopedics: Europe Small Molecule Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Immunology
  • 7.6.1 Overview
  • 7.6.2 Immunology: Europe Small Molecule Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.7 Rare Diseases
  • 7.7.1 Overview
  • 7.7.2 Rare Diseases: Europe Small Molecule Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.8 Other Therapeutic Areas
  • 7.8.1 Overview
  • 7.8.2 Other Therapeutic Areas: Europe Small Molecule Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Europe Small Molecule Drug Delivery Market Analysis – by Process/Phase

8.1 Target Discovery
  • 8.1.1 Overview
  • 8.1.2 Target Discovery: Europe Small Molecule Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Target Validation
  • 8.2.1 Overview
  • 8.2.2 Target Validation: Europe Small Molecule Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Lead Generation and Refinement
  • 8.3.1 Overview
  • 8.3.2 Lead Generation and Refinement: Europe Small Molecule Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Preclinical Development
  • 8.4.1 Overview
  • 8.4.2 Preclinical Development: Europe Small Molecule Drug Delivery Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Europe Small Molecule Drug Delivery Market – Europe Analysis

9.1 Overview

9.2 Europe
  • 9.2.1 Europe Small Molecule Drug Delivery Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 9.2.1.1 Europe Small Molecule Drug Delivery Market – Revenue and Forecast Analysis – by Country
  • 9.2.1.1 UK: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.2.1.1.1 UK: Europe Small Molecule Drug Delivery Market Breakdown, by Therapeutic Area
    • 9.2.1.1.2 UK: Europe Small Molecule Drug Delivery Market Breakdown, by Process/Phase
  • 9.2.1.2 Germany: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.2.1.2.1 Germany: Europe Small Molecule Drug Delivery Market Breakdown, by Therapeutic Area
    • 9.2.1.2.2 Germany: Europe Small Molecule Drug Delivery Market Breakdown, by Process/Phase
  • 9.2.1.3 France: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.2.1.3.1 France: Europe Small Molecule Drug Delivery Market Breakdown, by Therapeutic Area
    • 9.2.1.3.2 France: Europe Small Molecule Drug Delivery Market Breakdown, by Process/Phase
  • 9.2.1.4 Russia: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.2.1.4.1 Russia: Europe Small Molecule Drug Delivery Market Breakdown, by Therapeutic Area
    • 9.2.1.4.2 Russia: Europe Small Molecule Drug Delivery Market Breakdown, by Process/Phase
  • 9.2.1.5 Italy: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.2.1.5.1 Italy: Europe Small Molecule Drug Delivery Market Breakdown, by Therapeutic Area
    • 9.2.1.5.2 Italy: Europe Small Molecule Drug Delivery Market Breakdown, by Process/Phase
  • 9.2.1.6 Rest of Europe: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
    • 9.2.1.6.1 Rest of Europe: Europe Small Molecule Drug Delivery Market Breakdown, by Therapeutic Area
    • 9.2.1.6.2 Rest of Europe: Europe Small Molecule Drug Delivery Market Breakdown, by Process/Phase

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments

12. Company Profiles

12.1 Merck KGaA
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 GlaxoSmithKline plc
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 AstraZeneca
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Boehringer Ingelheim International GmbH
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Allergan Plc
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Pfizer Inc.
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Bristol-Myers Squibb Company
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 Johnson & Johnson Services, Inc.
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights
13.2 List of Abbreviations

The List of Companies - Europe Small Molecule Drug Delivery Market

  • Merck KGaA
  • GlaxoSmithKline plc
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Allergan Plc
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd

    • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)